Fundamental Analysis of CONMED Corporation - Growth / Value Index
CNMD - Valuation Highlights
Valuation Analysis
Tsr Value Index - Excellent Score of 82.81
Undervalued - Price to Intrinsic Value of 0.0033
Price to Earning Ratio is 13.34 and EV to EBITDA is 11.81 suggesting company is undervalued.
Tremendous increasing in Book Value last 3 year
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 13.16 | 10.97 | -56.83 % | |
| Price to Book | 1.52 | 1.51 | -14.54 % | 1.45 |
| Price to Sales | 1.09 | 1.11 | -11.83 % | |
| Enterprise Value to EBITDA Multiple | 11.71 | 11.65 | -18.58 % |
CNMD - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 9.0
Earning Yield of 7.50 %
Company Earning excess return
Annual Net Profit in last 3 years is trending up
Good Return on Equity of 11.58% is achieved by the company
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 11.58 | 13.76 | 97.94 % | 2.14 |
| Return On Asset | 4.78 | 5.74 | 127.81 % | 0.920 |
| Net Profit Margin | 8.31 | 10.13 | 104.23 % | 6.26 |
| Operating Profit Margin | 12.99 | 81.85 | 1279.77 % | 11.15 |
| EBITDA Margin | 14.98 | 15.33 | 5.80 % | 11.15 |
Highlights
| Market Cap | 1445.91 M |
| Enterprise Value | 2327.23 M |
| Price/Book TTM | 1.52 |
| Outstanding Share | 30954.96 K |
| Float/ Outstanding Share | 99.11% |
| Dividend Yield | 1.69 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.940 |
| Peter Lynch Ratio | 10.00 |
| Piotroski F Score | 9.00 |
| Altman Z Score | 1.95 |
| Sloan Ratio | -0.0093 |
| Peter Lynch Fair Value | 23.05 |
CNMD - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 104.23%
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1326.25 M | 11.85 % | 6.56 % |
| Gross Profit | 743411 K | 108.81 % | 5.95 % |
| EBITDA | 198697 K | 18.33 % | 11.55 % |
| Net Profit | 110196 K | 128.43 % | 254.89 % |
| EPS | 3.55 | 131.63 % | NA |
CNMD - Stability Highlights
Stability Analysis
Decreasing debt with Increasing revenue
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.941 | -19.40 % | 0.879 |
| Cash Ratio | 0.088 | 12.47 % | |
| Quick Ratio | 1.05 | 10.20 % | 1.00 |
| Shareholders Equity | 41.74 | 15.09 % | |
| Debt to EBITDA | 4.52 | -21.40 % |
Historical Valuation Ratios of CONMED Corporation
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of CONMED Corporation
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of CONMED Corporation
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of CONMED Corporation
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)